| Product NDC: | 0703-4805 |
| Proprietary Name: | Mesna |
| Non Proprietary Name: | Mesna |
| Active Ingredient(s): | 100 mg/mL & nbsp; Mesna |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0703-4805 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075764 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020501 |
| Package NDC: | 0703-4805-03 |
| Package Description: | 10 VIAL, MULTI-DOSE in 1 CARTON (0703-4805-03) > 10 mL in 1 VIAL, MULTI-DOSE (0703-4805-01) |
| NDC Code | 0703-4805-03 |
| Proprietary Name | Mesna |
| Package Description | 10 VIAL, MULTI-DOSE in 1 CARTON (0703-4805-03) > 10 mL in 1 VIAL, MULTI-DOSE (0703-4805-01) |
| Product NDC | 0703-4805 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mesna |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20020501 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | MESNA |
| Strength Number | 100 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cytoprotective Agent [EPC] |